In the intensive care management of septic shock, tracking how arterial vascular tone shifts across the initial two days of vasopressor infusion provides measurable prognostic value, yet it does not eclipse conventional clinical scoring systems. In a prospective observational investigation involving ninety-four adult patients admitted to the intensive care department at Antalya Training and Research Hospital, investigators monitored the vascular norepinephrine response index, abbreviated as VNERi, across forty-eight hours of treatment. The mathematical formulation derives this bed-accessible metric by dividing diastolic arterial pressure by the product of the standardized norepinephrine infusion rate and heart rate. While an isolated initial measurement taken at the point of vasopressor initiation failed to distinguish between patients who survived and those who died within twenty-eight days, following the metric continuously revealed distinct hemodynamic trajectories that correlated with survival. The team discovered that summary trajectory values, including the mean level and the direction of the slope across time, offered meaningful prognostic discrimination, demonstrating that serial evaluation of physiological responsiveness captures critical clinical information that a single initial reading entirely misses.
Nevertheless, bedside clinicians routinely encounter pronounced heterogeneity in how individual human vascular beds react to equivalent drug exposures. Certain critically ill individuals regain vascular tone promptly at modest infusion rates, whereas others manifest severe catecholamine-resistant vasoplegia that necessitates escalating pharmacological support. Diastolic arterial pressure serves as a direct bedside physiological proxy for systemic arterial tone, but interpreting this pressure in isolation overlooks the cardiac frequency and the pharmacological intensity required to sustain it. By explicitly incorporating heart rate alongside weight-adjusted norepinephrine dosage into the denominator, VNERi standardizes diastolic tone relative to total cardiovascular workload and adrenergic exposure without requiring invasive procedures or supplementary diagnostic expenses.
Previous investigations into this physiological construct had evaluated VNERi strictly as a static, post-hoc baseline metric extracted from historical databases, linking lower baseline values to elevated risk of hospital mortality. The investigators hypothesized in their pre-specified, institutional review board-approved protocol that tracking forty-eight-hour VNERi trajectories, specifically the arithmetic mean level and trajectory slope, would predict twenty-eight-day mortality significantly better than any single baseline assessment. Between December 2025 and June 2026, researchers consecutively screened one hundred eleven adult patients presenting with septic shock defined by standard Sepsis-3 consensus criteria, enrolling ninety-four individuals within six hours of initiating first-line norepinephrine while excluding patients who received alternative initial vasopressors, lacked informed consent, or presented with terminal illness.
The study protocol mandated the prospective recording of complete hemodynamic variables, including systolic, mean, and diastolic arterial pressures alongside heart rate and concurrent vasopressor dosages, at hours zero, four, six, twelve, twenty-four, thirty-six, and forty-eight. To maintain precise comparability across varying pharmacological regimens, all concurrent vasopressor administrations—such as adrenaline, vasopressin, phenylephrine, or dopamine—were standardized into weight-adjusted norepinephrine equivalents using established international conversion rules. Arterial lactate concentrations were measured in tandem at identical intervals, while comprehensive Sequential Organ Failure Assessment, or SOFA, scores were formally documented at hours zero, twenty-four, and forty-eight. To assess renal outcomes prospectively across seven days, serum creatinine levels, hourly urinary output, and Kidney Disease: Improving Global Outcomes staging criteria were tracked daily in all individuals free of acute kidney dysfunction at study entry.
Across the entire prospective cohort of ninety-four patients, overall twenty-eight-day all-cause mortality reached thirty-two percent, corresponding to thirty deaths and sixty-four survivors. Non-survivors presented with a significantly higher median age of sixty-eight years compared with sixty-one and a half years among survivors, whereas baseline acute physiology measures demonstrated notable equivalence between groups. Crucially, the overall cohort exhibited a largely preserved initial vascular responsiveness, presenting a median baseline VNERi of 7.5. Only forty-four percent of participants exhibited baseline values below the published historical risk nadir of 6.7, creating a high-response physiological baseline that restricted the mathematical capacity of the initial reading alone to separate subsequent survival trajectories.
Statistical discrimination analyses decisively confirmed the primary study hypothesis regarding the superiority of dynamic trajectories over static entry measures. The isolated baseline VNERi measurement generated an area under the receiver operating characteristic curve of merely 0.59, failing to achieve statistical significance with an odds ratio per standard deviation increase of 0.64. Conversely, parameters summarizing the longitudinal trajectory across forty-eight hours demonstrated robust outcome separation. The mean level of VNERi, calculated as the integrated area under the curve divided by observation duration, achieved an area under the curve of 0.73, significantly outperforming the baseline reading in head-to-head DeLong testing with a p-value of 0.002. Similarly, the lowest recorded value across the observation window yielded an area under the curve of 0.69, while the final forty-eight-hour value achieved 0.72. Following rigorous Benjamini-Hochberg false discovery rate adjustments for multiplicity, the superior discrimination of the mean trajectory level remained statistically robust.
Longitudinal mixed-effects modeling incorporating random intercepts and random slopes highlighted divergent physiological paths between outcome groups across the forty-eight-hour window. Among patients who survived, the natural logarithm of VNERi exhibited a sustained progressive climb, rising by 7.4 percent every ten hours, whereas non-survivors displayed persistent vascular suppression with values declining by 6.4 percent per ten-hour increment. This divergence produced a statistically significant interaction between elapsed time and clinical outcome. Landmark survival analyses executed at twenty-four and forty-eight hours confirmed that minimum observed index values retained an independent statistical link to subsequent survival, indicating that surviving the initial hours did not account for the observed separation.
Despite confirming the prognostic merit of trajectory tracking, head-to-head benchmarking against standard bedside clinical instruments demonstrated that VNERi does not surpass established measures of evolving organ failure. Standalone dynamic clinical parameters exhibited superior discrimination for twenty-eight-day mortality, led by the twenty-four-hour change in SOFA score, which attained an area under the curve of 0.84, rising to 0.85 when evaluated across forty-eight hours. Lactate clearance measured at twenty-four hours achieved an area under the curve of 0.75. When researchers recomputed VNERi metrics strictly within a window-matched zero-to-twenty-four-hour frame to guarantee methodological fairness, the mean twenty-four-hour VNERi area under the curve fell to 0.67, which was significantly inferior to twenty-four-hour delta-SOFA on DeLong testing with a p-value of 0.019, while demonstrating comparable predictive accuracy to twenty-four-hour lactate clearance.
Nevertheless, adding VNERi trajectories to dynamic multivariable clinical models yielded small but statistically significant incremental prognostic gains. A dynamic baseline reference model combining patient age, twenty-four-hour change in SOFA score, and twenty-four-hour lactate clearance achieved a strong baseline area under the curve of 0.86. Incorporating the window-matched twenty-four-hour minimum VNERi elevated the area under the curve to 0.89, producing an integrated discrimination improvement of 0.062 with a likelihood ratio test p-value of 0.018. Integrating the window-matched mean level produced an identical area under the curve of 0.89 alongside an integrated discrimination improvement of 0.047. However, investigative models underscored that the vast majority of prognostic power in early septic shock stems from broader systemic organ failure resolution rather than vascular responsiveness alone, with static base models expanding dramatically upon incorporating changing organ failure scores.
The biological interdependence between vascular responsiveness and overall organ dysfunction became particularly evident within multivariable time-dependent survival modeling. When researchers adjusted the time-varying VNERi Cox model for age and time-varying SOFA scores modeled as step functions, the protective association of elevated instantaneous VNERi attenuated to a non-significant hazard ratio of 0.68 with a p-value of 0.077, while time-varying SOFA strongly dictated mortality risk with a hazard ratio of 1.26 per point. Although instantaneous VNERi regained formal statistical significance in a fully adjusted multivariable architecture containing concurrent norepinephrine dosage and circulating lactate, the resulting hazard ratio of 0.21 possessed an exceptionally wide confidence interval spanning from 0.05 to 0.78. This analytical fragility indicates that the vascular index shares extensive variance with progressive multi-organ recovery and possesses, at most, a modest distinct physiological signal.
To explore whether discrete biological subpopulations existed within the longitudinal data, the authors applied a latent class mixed model to forty-eight-hour log-VNERi values, discovering three reproducible hemodynamic phenotypes distinguished by baseline level and trajectory slope. The high-rising or recovering phenotype represented fifty-two percent of the cohort with forty-nine patients, characterized by high initial values that steadily increased over time, exhibiting a low twenty-eight-day mortality rate of sixteen percent. The intermediate-falling or worsening phenotype comprised thirty-four individuals who began with moderate vascular tone that progressively deteriorated, suffering fifty percent mortality. The low-persistent or refractory phenotype contained eleven patients who maintained profoundly suppressed vascular indices throughout forty-eight hours, experiencing forty-six percent mortality. Kaplan-Meier survival curves separated distinctly across classes with a log-rank p-value of 0.002, yielding adjusted hazard ratios of 3.72 for intermediate-falling and 4.98 for low-persistent trajectories relative to the recovering class.
In an exploratory secondary analysis focusing on renal pathophysiology among eighty-three patients who presented without baseline acute kidney injury, baseline VNERi demonstrated a notable divergence between organ-specific vulnerability and systemic mortality. Fifty-five individuals, or sixty-six percent of this kidney-intact subpopulation, developed sepsis-associated acute kidney injury of KDIGO stage two or higher within the first seven days. Unlike its failure to predict twenty-eight-day mortality, the single baseline VNERi successfully separated patients who subsequently developed kidney injury from those who remained free of renal compromise, generating an area under the curve of 0.75. Because diastolic arterial pressure serves as a primary hemodynamic determinant of renal perfusion pressure, these observations suggest that a blunted initial vascular response to norepinephrine may impair sensitive renal microvascular beds days before manifesting as systemic circulatory collapse.
The authors emphasized several fundamental methodological constraints that govern how these findings must be interpreted by the clinical and scientific community. Conducted at a single tertiary care center with ninety-four patients and thirty mortality events, the investigation was conceptualized as a proof-of-concept study rather than a definitive multicenter trial, which renders complex multivariable regression models and small subphenotype hazard ratios vulnerable to statistical instability. Furthermore, because consecutive enrollment captured a patient population characterized predominantly by low baseline vasopressor requirements and preserved vascular tone, the observed findings cannot be extrapolated directly to severely hyporesponsive cohorts with refractory septic shock. Post-hoc subgroup testing confirmed that the previously reported inverted-J relationship and specific categorical risk thresholds did not replicate in this case-mix, underscoring that static cut-points derived from retrospective databases cannot be applied uniformly across institutions without local validation.
Ultimately, serial bedside calculation of the vascular norepinephrine response index offers intensive care teams an inexpensive, automated window into dynamic vascular tone that significantly outperforms uncalibrated static measurements taken at shock onset. Because the index utilizes routine arterial line tracings, standard telemetry, and documented pump infusion rates, it introduces zero procedural risk and negligible financial overhead to daily clinical workflows. However, because its longitudinal trajectory does not surpass established dynamic clinical markers such as the change in SOFA score or lactate clearance, VNERi cannot serve as an independent replacement for comprehensive organ failure assessments. Instead, investigators regard these longitudinal trajectory patterns and latent phenotypes as compelling, hypothesis-generating foundations that must undergo rigorous prospective testing in broader, severely hyporesponsive patient populations before clinician-guided vasopressor titration protocols can be substantiated.
Subject of Research: Prospective evaluation of serial vascular norepinephrine response index trajectories in adults with early septic shock
Article Title: Bedside monitoring of the vascular response to norepinephrine in early septic shock: VNERi trajectories and comparison with dynamic clinical measures
Article References: Karancı, Y., Çiyiltepe, F., Akçın, G., & Beggi, H. (2026). Bedside monitoring of the vascular response to norepinephrine in early septic shock: VNERi trajectories and comparison with dynamic clinical measures. Journal of Clinical Monitoring and Computing. https://doi.org/10.1007/s10877-026-01516-x
Image Credits: AI Generated
DOI: 10.1007/s10877-026-01516-x
Keywords: Septic Shock, Norepinephrine, Vascular Tone, Hemodynamic Monitoring, VNERi, Intensive Care Medicine, SOFA Score, Lactate Clearance, Arterial Pressure, Vasopressor Therapy, Vasoplegia, Prognostic Biomarkers, Acute Kidney Injury, Latent Class Analysis, Clinical Trajectories, Critical Care Research, Cardiovascular Dynamics
News Source: Ophelia Keating. (November 18, 2026). Tracking Norepinephrine Response Trajectories Over Time Predicts Septic Shock Outcomes. Scienmag.



